Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation

American Journal of Medicine

Volumn 120, Issue 10, 2007, Pages 880-885

  Batcher, Elizabeth L ^a   Tang, X Charlene ^a   Singh, Bramah N ^a   Singh, Steven N ^b   Reda, Domenic J ^a   Hershman, Jerome M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Amiodarone; Hypothyroidism; Sotalol; Thyroid

Indexed keywords

AMIODARONE; LEVOTHYROXINE; PLACEBO; SOTALOL; THYROTROPIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SOTALOL; THYROID DISEASES; THYROXINE;

EID: 34548823481     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.04.022     Document Type: Article

References (25)

1. Melmed S., Nademanee K., Reed A.W., et al. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after amiodarone administration. J Clin Endocrinol Metab 53 (1981) 997-1001
2. Martino E., Bartalena L., Bogazzi F., and Braverman L.E. Effects of amiodarone on the thyroid. Endocr Rev 22 2 (2001) 240-254
3. Harjai K.J., and Licata A.A. Effects of amiodarone on thyroid function. Ann Intern Med 126 (1997) 63-73
4. Martino E., Aghini-Lombardi F., Mariotti S., et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin Endocrinol 26 (1987) 227-237
5. Trip M.D., Wiersinga W., and Plomp T.A. Incidence, predictability and pathogenesis of amiodarone induced thyrotoxicosis and hypothyroidism. Am J Med 91 5 (1991) 507-511
6. Martino E., Aghini-Lombardi F., Bartalena L., et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with anutoimmune thyroid disease. Arch Intern Med 23 (1994) 2722-2726
7. Singh B.N., Singh S.N., Reda D.J., et al. Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. Veterans Affairs Cooperative Study. N Engl J Med 352 (2005) 1861-1872
8. Wahlberg P., Wennstrom J., and Ekelund P. Control of thyrotoxicosis with sotalol. Ann Clin Res 8 (1976) 415-417
9. Perrild H., Hansen J.M., Skovsted L., and Christensen L.K. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin Endocrinol 18 (1983) 139-142
10. Nademanee K., Singh B.N., Callahan B., et al. Amiodarone, thyroid hormone indexes and altered thyroid function: long term serial effects in patients with cardiac arrhythmias. Am J Cardiol 58 (1986) 981-986
11. Kennedy R.L., Griffiths H., and Gray T.A. Amiodarone and the thyroid. Clin Chem 35 (1989) 1882-1887
12. Wiersinga W.M., and Trip M.D. Amiodarone and thyroid hormone metabolism. Postgrad Med J 62 (1986) 909-914
13. Franklyn J.A., Gammage M.D., and Sheppard M.C. Amiodarone and thyroid hormone effects on anterior pituitary hormone gene expression. Clin Endocrinol (Oxf) 27 (1987) 373-382
14. Tedelind S., Larsson F., Johanson C., et al. Amiodarone inhibits thyroidal iodine transport in vitro by a cyclic AMP and iodine independent mechanism. Endocrinology 147 (2006) 2936-2943 (Epub 2006 Mar 9)
15. Martino E., Safran M., Aghini-Lombardi F., et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 101 (1984) 28-34
16. Hollowell J.G., Staehling N.W., Flanders D., et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 (2002) 489-499
17. Albert S.G., Alves L.E., and Rose E.P. Thyroid dysfunction during chronic amiodarone therapy. J Am Coll Cardiol 9 (1987) 175-183
18. Hershman J.M., Nademanee K., Sugawara M., et al. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol 111 (1986) 193-199
19. Nademanee K., Piwonka P., Singh B.N., and Hershman J.M. Amiodarone and thyroid function. Prog Cardiovasc Dis 31 (1989) 427-437
20. Biondi B., and Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24 (2004) 1-13
21. Rondondi N., Newman A.B., Vittinghoff E., et al. Subclinical hypothyroidism and the risk for heart failure, other cardiovascular events and death. Arch Intern Med 165 (2005) 2460-2466
22. Walsh J.P., Bremner A.P., Bulsara M.K., et al. Subclinical thyroid disease as a risk factor for cardiovascular disease. Arch Intern Med 165 (2005) 2467-2472
23. Cappola A., Fried L., Arnold A., et al. Thyroid status, cardiovascular risk and mortality in older adults. JAMA 295 (2006) 1033-1041
24. Surks M.I., Ortiz E., Daniels G.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 (2004) 228-238
25. Martino E., Macchia E., Aghini-Lombardi F., et al. Is humoral thyroid autoimmunity relevant in amiodarone iodine-induced thyrotoxicosis AIIT?. Clin Endocrinol 24 (1986) 627-633